|
Search
Collections
Benchmarks
Upload document
Product
Cisplatin + CKM + Celecoxib + DC Vaccine
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
4 indications
Indication
Ovarian Cancer
Indication
Cancer
Indication
Ovarian
Indication
Ovarian Neoplasms
Clinical trial
A PHASE 1-2 NEOADJUVANT DOSE FINDING, SAFETY, AND IMMUNOLOGIC EFFICACY TRIAL OF INTENSIVE LOCOREGIONAL CHEMOIMMUNOTHERAPY FOR RECURRENT OVARIAN CANCER AND TUMOR-SPECIFIC INTRANODAL AUTOLOGOUS ALPHA-DC1 VACCINES
Status:
, Estimated PCD: 2025-12-31
